BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27908592)

  • 1. Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties.
    Lau KM; Ma FM; Xia JT; Chan QKY; Ng CF; To KF
    Exp Cell Res; 2017 Jan; 350(1):199-209. PubMed ID: 27908592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
    Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
    J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-D-glucuronide-induced cholestasis.
    Zucchetti AE; Barosso IR; Boaglio AC; Basiglio CL; Miszczuk G; Larocca MC; Ruiz ML; Davio CA; Roma MG; Crocenzi FA; Pozzi EJ
    Hepatology; 2014 Mar; 59(3):1016-29. PubMed ID: 24115158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.
    Lau KM; To KF
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P; Pang Y; Filardo EJ; Dong J
    Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Doses of Nonylphenol Promote Growth of Colon Cancer Cells through Activation of ERK1/2 via G Protein‒Coupled Receptor 30.
    Xie M; Liang JL; Huang HD; Wang MJ; Zhang T; Yang XF
    Cancer Res Treat; 2019 Oct; 51(4):1620-1631. PubMed ID: 31096733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
    Gao F; Ma X; Ostmann AB; Das SK
    Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
    Wróbel AM; Gregoraszczuk EŁ
    Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.
    Thomas P; Dong J
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):175-9. PubMed ID: 17088055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.
    Broselid S; Berg KA; Chavera TA; Kahn R; Clarke WP; Olde B; Leeb-Lundberg LM
    J Biol Chem; 2014 Aug; 289(32):22117-27. PubMed ID: 24962572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
    Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries.
    Yu X; Stallone JN; Heaps CL; Han G
    PLoS One; 2018; 13(1):e0191418. PubMed ID: 29360846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor.
    Chamson-Reig A; Sorianello EM; Catalano PN; Fernández MO; Pignataro OP; Libertun C; Lux-Lantos VA
    Endocrinology; 2003 Jul; 144(7):2957-66. PubMed ID: 12810551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A.
    Bouskine A; Nebout M; Mograbi B; Brücker-Davis F; Roger C; Fenichel P
    Endocrinology; 2008 Feb; 149(2):565-73. PubMed ID: 18039775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.